The Business Research Company’s global market reports are now updated with the latest market sizing
Read MoreThe Dermo Cosmetics market size is expected to reach $83.49 billion in 2030 at a CAGR of 10.0%, driven by rising UV radiation exposure.
Read More
The Deoxyribonucleic Acid (DNA) Damage Repair Enzyme Mixes market size is expected to reach $0.67 billion in 2030 at a CAGR of 10.0%, driven by increasing genetic disorder prevalence.
Read More
The Artificial Intelligence (AI) Dermatology Imaging market size is expected to reach $2.9 billion in 2030 at a CAGR of 21.0%, driven by rising skin cancer incidence.
Read More
The Adeno-Associated Virus (AAV) Packaging Services market size is expected to reach $2.52 billion in 2030 at a CAGR of 11.3%, driven by gene therapy demand.
Read MoreThe wound skin substitutes market is projected to reach $1.91B by 2030, driven by chronic wound prevalence, diabetes growth, regenerative medicine, advanced wound care, and outpatient clinics.
Read MoreThe wearable neurotech market is projected to reach $5.34B by 2030, driven by remote neuro monitoring, cognitive enhancement tools, neurodigital therapeutics, and consumer brain-computer interfaces.
Read MoreFoot and mouth disease diagnostics market to reach $1.56B by 2030 at 8.1% CAGR, driven by rapid detection, PCR kits, point-of-care testing, and livestock health monitoring.
Read MoreFever screening systems market to reach $3.48B by 2030 at 9.0% CAGR, driven by contactless screening, AI monitoring, smart infrastructure, and workplace safety demand.
Read MoreFetal aneuploidy confirmation testing market to reach $2.36B by 2030 at 10.6% CAGR, driven by NIPT demand, AI genetics, precision medicine, and advanced prenatal diagnostics.
Read More
FOBT market to reach $2.67B by 2030 at 7.7% CAGR, driven by non-invasive screening, at-home test adoption, early colorectal cancer detection, and digital health integration.
Read More